Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Population homogeneity for the antibody response to COVID-19 BNT162b2/Comirnaty vaccine is only reached after the second dose across all adult age ranges
João Faro Viana, Marie‐Louise Bergman, Lígia Antunes Gonçalves, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Development of therapeutic antibodies for the treatment of diseases
Zeng Wang, Guoqing Wang, Huaqing Lu, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 75
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine
Annalisa Ciabattini, G Pastore, Fabio Fiorino, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 97
Recent review of COVID-19 management: diagnosis, treatment and vaccination
Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1120-1148
Open Access | Times Cited: 55
Optimizing COVID-19 vaccination programs during vaccine shortages
Kaihui Liu, Yijun Lou
Infectious Disease Modelling (2022) Vol. 7, Iss. 1, pp. 286-298
Open Access | Times Cited: 47
SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia
Marianna Karachaliou, Gemma Moncunill, Ana Espinosa, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 38
Lipid-Based Nanotechnology: Liposome
Yanhao Jiang, Wenpan Li, Zhiren Wang, et al.
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 34-34
Open Access | Times Cited: 30
Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2
Feyza Gül Özbay Kurt, Alisa Lepper, Catharina Gerhards, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Managing the Impact of COVID-19 in Nursing Homes and Long-Term Care Facilities: An Update
Adam H. Dyer, Aoife Fallon, Claire Noonan, et al.
Journal of the American Medical Directors Association (2022) Vol. 23, Iss. 9, pp. 1590-1602
Open Access | Times Cited: 27
Secretory IgA and T cells targeting SARS-CoV-2 spike protein are transferred to the breastmilk upon mRNA vaccination
Juliana Gonçalves, A. Margarida Juliano, Nádia Charepe, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 12, pp. 100468-100468
Open Access | Times Cited: 38
Omicron variants breakthrough infection elicited higher specific memory immunity than third dose booster in healthy vaccinees
Pei Yu, Zijian Liu, Zhuoqi Zhu, et al.
Virologica Sinica (2023) Vol. 38, Iss. 2, pp. 233-243
Open Access | Times Cited: 12
Human immune and gut microbial parameters associated with inter-individual variations in COVID-19 mRNA vaccine-induced immunity
Masato Hirota, Miho Tamai, Sachie Yukawa, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 12
Severe Breakthrough COVID-19 Cases during Six Months of Delta Variant (B.1.617.2) Domination in Poland
Piotr Rzymski, Monika Pazgan−Simon, Juliusz Kamerys, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 557-557
Open Access | Times Cited: 19
Reduced Antibody Acquisition with Increasing Age following Vaccination with BNT162b2: Results from Two Longitudinal Cohort Studies in The Netherlands
Lotus L. van den Hoogen, Mardi C. Boer, Abigail Postema, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1480-1480
Open Access | Times Cited: 18
Item-level heterogeneous treatment effects of selective serotonin reuptake inhibitors (SSRIs) on depression: implications for inference, generalizability, and identification
Joshua B. Gilbert, Fredrik Hieronymus, Elias Eriksson, et al.
Epidemiologic Methods (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
The heterogeneous mixing model of COVID-19 with interventions
Moran Duan, Zhen Jin
Journal of Theoretical Biology (2022) Vol. 553, pp. 111258-111258
Open Access | Times Cited: 12
Torquetenovirus viral load is associated with anti‐spike antibody response in SARS‐CoV‐2 mRNA BNT162b2 vaccinated kidney transplant patients
Sara Querido, Teresa Adragão, Iola Pinto, et al.
Clinical Transplantation (2022) Vol. 36, Iss. 12
Open Access | Times Cited: 10
Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222
Thomas Perkmann, Nicole Perkmann‐Nagele, Patrick Mucher, et al.
International Journal of Infectious Diseases (2021) Vol. 110, pp. 309-313
Open Access | Times Cited: 13
Enhancing the efficiency and stability of electrocatalysts for water splitting: NiCo-LDH nanosheet arrays at high current density
Xiaomei Wang, Tiantian Wang, Yongren Yu, et al.
CrystEngComm (2024) Vol. 26, Iss. 37, pp. 5144-5151
Closed Access | Times Cited: 1
Nanoparticle platform comprising lipid-tailed pH-sensitive carbon dots with minimal drug loss
Hongjae Kim, Kyoung Sub Kim, Kun Na
Journal of Controlled Release (2023) Vol. 361, pp. 373-384
Closed Access | Times Cited: 4
Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up
André Weigert, Marie‐Louise Bergman, Lígia Antunes Gonçalves, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 11
Systemic and Mucosal Humoral Immune Response Induced by Three Doses of the BNT162b2 SARS-CoV-2 mRNA Vaccines
Roberta Mancuso, Simone Agostini, Lorenzo Agostino Citterio, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1649-1649
Open Access | Times Cited: 7
Saliva molecular testing bypassing RNA extraction is suitable for monitoring and diagnosing SARS-CoV-2 infection in children
Marta Alenquer, Tiago Milheiro Silva, Onome Akpogheneta, et al.
PLoS ONE (2022) Vol. 17, Iss. 6, pp. e0268388-e0268388
Open Access | Times Cited: 4
Experimental VLP vaccine displaying a furin antigen elicits production of autoantibodies and is well tolerated in mice
Vili Lampinen, Markus J. T. Ojanen, F. Sánchez Muñoz, et al.
Nanoscale Advances (2024)
Open Access
Optimal control strategy for the administration of the third vaccine dose in the treatment of pandemic COVID-19
I. Khaloufi, Youssef Benfatah, Marouane Lafif, et al.
Mathematical Modeling and Computing (2023) Vol. 10, Iss. 3, pp. 841-853
Open Access | Times Cited: 1
Human immune and gut microbial parameters associated with inter-individual variations in COVID-19 mRNA vaccine-induced immunity
Masato Hirota, Miho Tamai, Sachie Yukawa, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top